Dr. John Cush RheumNow
4 years 10 months ago
Food for Thought: "ITIS" Diet for Patients with Rheumatoid Arthritis: Dr. Akhil Sood ( @AkhilSoodMD)
discusses abstract #1699 presented at the ACR21 annual meeting.
https://t.co/wSPuGimFjP https://t.co/nc7bg1Odjk
Dr. John Cush RheumNow
4 years 10 months ago
Infection Risk in Offspring Exposed to Biologics: Dr. Rachel Tate ( @uptoTate)
https://t.co/oYpKpCix7Q https://t.co/0yIk9Qhc1h
Dr. John Cush RheumNow
4 years 10 months ago
Dr. Janet Pope and Dr. Jeffrey Sparks discuss the importance of lung and several lung-related abstracts presented at the ACR21 annual meeting.
https://t.co/s5sl6tdKwP
Dr. John Cush RheumNow
4 years 10 months ago
RheumNow Podcast - 60/40/20 Interview with Dr. Ed Keystone
https://t.co/gLUfazvsXA
Dr. John Cush RheumNow
4 years 10 months ago
Multimorbidity, the presence of multiple overlapping chronic comorbid conditions, is increasingly common at first presentation of rheumatoid arthritis (RA), increasing as a person gets older and/or during disease progression.
https://t.co/L6NJhVwOws https://t.co/GgRSCaYTZ6
Dr. Jack Cush interviews Professor Edward Keystone, MD (University of Toronto) on the origins and science behind the 60/40/20 benchmark and outcomes in rheumatoid arthritis.
The arsenal of therapeutics for psoriatic arthritis continues to increase. Risankizumab is an IL-23 inhibitor to the p19 subunit, currently being investigated for treatment of psoriatic arthritis.
Appropriate assessment and management of comorbidities and multimorbidity in patients with RA is vital for overall health and well-being of the patient, as well as to encourage treatment adherence, and address social, psychological and quality of life factors.
Dr. John Cush RheumNow
4 years 10 months ago
"The reasonable man adapts himself to the world; the unreasonable one persists in trying to adapt the world to himself. Therefore, all progress depends on the unreasonable man."
- George Bernard Shaw https://t.co/9bAJfkF7lH
Dr. John Cush RheumNow
4 years 10 months ago
Flare Patterns in Autoinflammatory Syndrome During Pandemic: Dr. Yuz Yusof ( @Yuz6Yusof) discusses abstract #1083 presented at the #ACR21 annual meeting.
https://t.co/i0VU3NEe7F https://t.co/DZkB5TgG3N
Dr. John Cush RheumNow
4 years 10 months ago
RA Treatment Conundrums: Dr. Janet Pope ( @Janetbirdope ) reviews abstracts #1252, #1442, #1438, #1444 and #1443 at the #ACR21 annual meeting.
https://t.co/ftlRAq0CNK https://t.co/nnT37wG8l9
Little is known about the safety of newer biologic use during pregnancy, especially in patients who either conceive while on a biologic or must remain on a biologic during pregnancy (often the case with IBD and inflammatory arthritis).
